Edap TMS SA (EDAP)
2.49
+0.04
(+1.63%)
USD |
NASDAQ |
Nov 21, 16:00
2.50
+0.01
(+0.40%)
After-Hours: 20:00
Edap TMS Enterprise Value: 68.17M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 68.17M |
| November 20, 2024 | 66.68M |
| November 19, 2024 | 64.46M |
| November 18, 2024 | 63.34M |
| November 15, 2024 | 66.68M |
| November 14, 2024 | 69.28M |
| November 13, 2024 | 73.36M |
| November 12, 2024 | 73.73M |
| November 11, 2024 | 70.02M |
| November 08, 2024 | 70.95M |
| November 07, 2024 | 77.07M |
| November 06, 2024 | 80.97M |
| November 05, 2024 | 78.18M |
| November 04, 2024 | 75.59M |
| November 01, 2024 | 81.89M |
| October 31, 2024 | 83.38M |
| October 30, 2024 | 86.72M |
| October 29, 2024 | 87.09M |
| October 28, 2024 | 83.38M |
| October 25, 2024 | 77.07M |
| October 24, 2024 | 69.28M |
| October 23, 2024 | 65.20M |
| October 22, 2024 | 72.80M |
| October 21, 2024 | 78.18M |
| October 18, 2024 | 76.33M |
| Date | Value |
|---|---|
| October 17, 2024 | 74.10M |
| October 16, 2024 | 77.07M |
| October 15, 2024 | 77.81M |
| October 14, 2024 | 75.96M |
| October 11, 2024 | 72.99M |
| October 10, 2024 | 72.99M |
| October 09, 2024 | 72.99M |
| October 08, 2024 | 75.22M |
| October 07, 2024 | 75.59M |
| October 04, 2024 | 73.73M |
| October 03, 2024 | 71.51M |
| October 02, 2024 | 73.36M |
| October 01, 2024 | 76.33M |
| September 30, 2024 | 70.39M |
| September 27, 2024 | 75.13M |
| September 26, 2024 | 77.36M |
| September 25, 2024 | 79.21M |
| September 24, 2024 | 81.81M |
| September 23, 2024 | 81.44M |
| September 20, 2024 | 84.04M |
| September 19, 2024 | 84.04M |
| September 18, 2024 | 85.15M |
| September 17, 2024 | 87.75M |
| September 16, 2024 | 91.09M |
| September 13, 2024 | 91.09M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
32.14M
Minimum
Mar 18 2020
400.67M
Maximum
Mar 03 2023
182.01M
Average
179.05M
Median
Jan 19 2021
Enterprise Value Benchmarks
| DBV Technologies SA | 1.221M |
| Cellectis SA | -28.39M |
| Genfit SA | 212.18M |
| Adaptimmune Therapeutics PLC | 26.67M |
| Akari Therapeutics PLC | 24.35M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.038M |
| Revenue (Quarterly) | 14.41M |
| Total Expenses (Quarterly) | 20.82M |
| EPS Diluted (Quarterly) | -0.187 |
| Gross Profit Margin (Quarterly) | 39.35% |
| Profit Margin (Quarterly) | -48.85% |
| Earnings Yield | -25.28% |
| Normalized Earnings Yield | -23.64 |